When to act : If you meet clinical thresholds and desire predictable monthly costs, initiating a virtual consult is the quickest path to a tailored affordability plan
Tirzepatide offers very high efficacy for weight loss (more than semaglutide, based on recent evidence) most likely due to its dual mechanism, while semaglutide has established itself as a leader with its proven cardiovascular benefits, said Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP
However, C4 was more strongly associated with breast cancer among individuals with a luminal B-like (HER2-positive or negative) subtype than other surrogate subtypes
The relationship between GLP-1 medications and each may also be very different
Injectable tirzepatide produces approximately 20.2% weight loss at 72 weeks (at maximum dose in the SURMOUNT-5 trial)